ABVC BioPharma Inc
ABVC
Market Cap$7.7M
Close$
$-2.58
183% downside
Current Fair Value
183% downsideOvervalued by 183% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.70 Million |
|---|---|
| Enterprise Value | $9.80 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.43 |
| Beta | 0.81 |
| Outstanding Shares | 11,321,277 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.62 |
|---|---|
| PEG | 0.79 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 19.28 |
| Enterprise Value to EBIT | -5.28 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.42 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About ABVC BioPharma Inc
34 employees